UnknownNot Applicable

A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES

420 participantsStarted 2020-10-01

Plain-language summary

This is a prospective single center, randomized controlled clinical study aimed to compare the clinical and angiographic follow-up results of patients with in-stent restenosis(ISR) after coronary drug eluting stent(DES) implantation treated by fractional flow reserve -guided and angiography guided drug eluting balloon(DEB) intervention. This study intends to confirm the clinical benefits of optimizing DEB intervention of DES-ISR by FFR.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. ISR in bare metal stents and biodegradable stents
✕. Complicated with immune diseases
✕. ISR in left main DES
✕. Suffer from renal failure requiring dialysis treatment or is undergoing dialysis treatment
✕. Severe cardiac insufficiency (LVEF \<30%)
✕. Subjects with ST segment elevation myocardial infarction within 7 days of onset of chest pain
✕. Pregnant or lactating women
✕. Combined with other diseases, life expectancy \<1 year

What they're measuring

target vessel failure

Timeframe: 12 month

Trial details

NCT IDNCT04518826

SponsorShanghai Zhongshan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-01

Contact for this trial

Qing Qin, MD

021-64041990 qin.qing@zs-hospital.sh.cn

View on ClinicalTrials.gov More In Stent Restenosis trials